Residents & Alumni
PGY-5
Raymond Luke, M.D., D.O. PGY-V
I was born in Cairo, Egypt and graduated with honors from Faculty of medicine, Cairo University. I completed my residency in Radiation Oncology at National Cancer Institute, Egypt. I worked for 6 years as radiation oncologist in Cairo before migrating to the United States. Once I moved to the United States, I focused on research for the treatment of HCV genotype 4. I received my medical degree from New York College of Osteopathic medicine. I am a member of the Sigma Sigma Phi Honor Society. I completed a preliminary year of Medicine at Ichan School of Medicine- Queens Hospital followed by internship year in Surgery at Albert Einstein School of Medicine- Montefiore. I received the intern of the year award from the department of Surgery at Montefiore. In my spare time, I enjoy reading, walking, biking, playing soccer and meeting up with my friends and family. My research interests include Radiation Therapy to the Spine, Multiple Myeloma and Intra Operative Radiation Therapy.
- R. Luke, H. Ashamalla, L.M. Graves, P.R. Graves, Investigation of a Mitochondrial to Nuclear Signaling Pathway Induced by Onc201,International Journal of Radiation Oncology*Biology*Physics, Volume 111, Issue 3, Supplement, 2021, Page e253, ISSN 0360-3016, https://doi.org/10.1016/j.ijrobp.2021.07.841.
- Mark D, Gilbo P, Meshrekey R and Ghaly M (2019) Local Radiation Therapy for Palliation in Patients with Multiple Myeloma of the Spine. Front. Oncol. July 2019; 9:601.
- Ahmad Latefi, Daniel Mark, Raymond Meshrekey, Eric Klein, Ferney Diaz-Molina, Yu Chen, Maged Ghaly.Kypho-IORT: A New Treatment Paradigm for Pathological Fractures, Int J Radiat Oncol Biol Phys September 2017 99(2):E520.
- Zaker Rana, Maged Ghaly, Kevin Kelley, Raymond Meshrekey, Jonathan Knisely.. (September, 2017). The Effect of Vertebral Endplate Involvement on Spine Radiosurgery Outcomes, Int J Radiat Oncol Biol Phys September 2017 992):E102.
PGY-3
Marshall Diven, M.D. PGY-3
I grew up in the heart of South Carolina and attended Wofford College located in Spartanburg, SC where I majored in biology. I then went to the Medical University of South Carolina School of Graduate Studies achieving a master’s degree in biomedical sciences with an emphasis in Immunology and Microbiology. My research focused on T-cell immunotherapy and harnessing microbial products to augment the T-cell mediated anti-tumor response in a melanoma mouse model. After successful defense of my thesis, I attended University of South Carolina School of Medicine Greenville in Greenville, SC where I obtained my medical degree. I then completed my intern year at a transitional year program at Redmond Regional Hospital located in Rome, Georgia prior to moving to Brooklyn. When I am not working I enjoy cycling, golfing and hiking among other things.
- Michelle H. Nelson, Marshall A. Diven, Logan W. Huff, and Chrystal M. Paulos, “Harnessing the Microbiome to Enhance Cancer Immunotherapy,” Journal of Immunology Research, vol. 2015, Article ID 368736, 12 pages, 2015. https://doi.org/10.1155/2015/368736.
- Nelson, M. H., Bowers, J. S., Bailey, S. R., Diven, M. A., Fugle, C. W., Kaiser, A. D., Wrzesinski, C., Liu, B., Restifo, N. P., … Paulos, C. M. (2016). Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning. Journal for immunotherapy of cancer, 4, 6. doi:10.1186/s40425-016-0110-8
Joy Ogunmuyiwa, M.D., MPH, PGY-3
I am a Dallas, Texas native and my family hails from Nigeria. I earned my undergraduate degree from Duke University where I studied biology and global health. I received my medical degree from Northeast Ohio Medical University. Prior to residency, I completed my Masters in Public Health at Harvard University where my work focused on the social and behavioral determinants of health, the widening inequality within the global health architecture, and designing equitable responses in global health challenges.
My research interests are primarily in health disparities and treatment outcomes, access to tertiary healthcare in low-income and resource-poor settings, as well as the design, implementation, and review of evidence-based health systems and interventions.
I happily serve on the executive board of the Society of Women in Radiation Oncology (SWRO) as the Diversity, Equity, and Inclusion chair. In my spare time, I enjoy photography, traveling, exploring NYC, and spending time with friends and family.
PGY-2
Ranjani Padmanabhan, M.D. PGY-2
I grew up in southern India and received my medical degree from University of Kerala. I worked at a Medical Oncology and bone marrow transplant unit before my Radiation Oncology Residency at Regional Cancer Center, India. After completing my residency, I worked as a consultant radiation Oncologist before Moving to the United States. I completed my fellowship in Brachytherapy and Advanced Radiation Oncology from Moffitt Cancer Center, Florida. After my general surgery internship at Albert Einstein-Montefiore medical center, I joined the Radiation Oncology program at New York-Presbyterian Brooklyn Methodist hospital. My research interests include Gynecological oncology, Pediatric oncology, and Palliative care.
- Hydrogel spacers in prostate radiotherapy: A Promising approach in lowering rectal toxicity. Padmanabhan R, Pinkawa M, Song DY. Hydrogel spacers in prostate radiotherapy: a promising approach to decrease rectal toxicity. Future Oncol. 2017 Dec; 13(29):2697-2708: 10.2217/fon-2017-0073. 2017 Nov 23. PMID: 29168659.
- Prophylactic Gabapentin is Associated with a Dramatic Reduction in Narcotic Utilization in Head and Neck Cancer Patients Undergoing Radiotherapy. Mandia, J.J. & Wang, H. & Padmanabhan, R. & Ferguson, Z. & Skoczylas, K. & Chaurasia, A.R. & Brennan, A.K. & Solano, C. & Lee, P. & Deeken, J. & Bajaj, Gopal (2020. International Journal of Radiation Oncology Biology Physics. 108. S160-S161. 10.1016/j.ijrobp.2020.07.924.)
- Patterns of failure in patients with recurrent high-grade glioma treated with Hypofractionated Stereotactic Re-Irradiation, pembrolizumab, and bevacizumab. Ranjani Padmanabhan1, Geoffrey Zhang1, Daniel Oliver1, Jasmine Graham1, G. Daniel Grass 1, Solmaz Sahebjam2, Hsiang-Hsuan Michael Yu.Poster Presentation.ASTRO 2021, Annual meeting.
We will be recruiting for 2 medical residency positions through ERAS 2023, the positions will start on 7/1/25.
Recent Alumni
Bassem Zaki
Class of 2001
Practice: Dartmouth-Hitchcock Medical Center, NH
Daniela Gidea-Addeo
Class of 2001
Practice: Yale New Haven Hospital, CT
Maged Ghaly
Class of 2002
Practice: Northwell Health Cancer Institute, NY
Aubrey Freiberg
Class of 2002
Practice: Downtown Bronx Medical Associates, NY
Biral Amin
Class of 2005
Practice: Riverside Medical Group, VA
Shravan Kambam
Class of 2005
Practice: Saint Michael's Medical Center, NJ
Marco Naguib
Class of 2006
Practice: Cancer Care Center of York County, ME
Mark Macedon
Class of 2009
Practice: Radiation Oncology Specialists Of Central VA, VA
Eva Bieniek
Class of 2009
Practice: Huron River Radiation Oncology Specialists, MI
Uma Swamy
Class of 2010
Practice: Eden Radiation Oncology Center, CA
Joana Emmolo
Class of 2010
Practice: Overlook Medical Center, NJ
Dhwani R. Parikh
Class of 2012
Practice: Memorial Sloan Kettering Basking Ridge, NJ
Amir Lavaf
Class of 2013
Practice: Desert Regional Medical Center, CA
Ajay Tejwani
Class of 2013
Practice: University of Kansas Medical Center, KS
Malcolm Mattes
Class of 2014
Practice: Rutgers Cancer Institute, NJ
John Kyle McCool
Class of 2016
Practice: Coastal Carolina Radiation Oncology, NC
David Hong
Class of 2017
Practice: Keck Hospital of USC, CA
Leila Tchelebi
Class of 2017
Practice: Penn State Cancer Institute, PA
Shaun Din
Class of 2018
Practice: Wyckoff Heights Medical Center, NY
Mark Ashamalla
Class of 2020
Practice: Stony Brook University Hospital, NY
Soni Vikram
Class 2021
Practice: Good Samaritan Hospital, NY
Joyson Kodiyan
Class 2021
Practice: CAMC Cancer Center Charleston, WV
Fan Zhu
Class 2022
Practice: MSKCC Proton Center, NY